KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES;KUNMING LONGJIN PHARMACEUTICAL CO., LTD.
发明人:
Ren Lai,Weihui Liu,Chengbo Long,Qiumin Lv
申请号：
US16347954
公开号：
US20190284258A1
申请日:
2017.11.08
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided are a Haemadipsa sylvestris antithrombotic peptide Sylvestin and the use thereof, falling within the technical field of biomedicine. The Haemadipsa sylvestris antithrombotic peptide sylvestin can inhibit FXIIa and kallikrein, has anti-thrombus/infarction effects and alleviates injuries caused by cerebral ischemia, and can also be used in the preparation of inhibitors of FXIIa and kallikrein and drugs for anti-thrombus/infarction and anti-cerebral ischemic injuries.
